nach oben

Metabolic Brain Disease

Erschienen in:

01.04.2015 | Original Paper

Improving the translation of animal ischemic stroke studies to humans

verfasst von: Glen C. Jickling, Frank R. Sharp

Erschienen in: Metabolic Brain Disease | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Despite testing more than 1,026 therapeutic strategies in models of ischemic stroke and 114 therapies in human ischemic stroke, only one agent tissue plasminogen activator has successfully been translated to clinical practice as a treatment for acute stroke. Though disappointing, this immense body of work has led to a rethinking of animal stroke models and how to better translate therapies to patients with ischemic stroke. Several recommendations have been made, including the STAIR recommendations and statements of RIGOR from the NIH/NINDS. In this commentary we discuss additional aspects that may be important to improve the translational success of ischemic stroke therapies. These include use of tissue plasminogen activator in animal studies; modeling ischemic stroke heterogeneity in terms of infarct size and cause of human stroke; addressing the confounding effect of anesthesia; use of comparable therapeutic dosage between humans and animals based on biological effect; modeling the human immune system; and developing outcome measures in animals comparable to those used in human stroke trials. With additional study and improved animal modeling of factors involved in human ischemic stroke, we are optimistic that new stroke therapies will be developed.

Abou-Chebl A, Lin R, Hussain MS, Jovin TG, Levy EI, Liebeskind DS, Yoo AJ, Hsu DP, Rymer MM, Tayal AH, Zaidat OO, Natarajan SK, Nogueira RG, Nanda A, Tian M, Hao Q, Kalia JS, Nguyen TN, Chen M, Gupta R (2010) Conscious sedation versus general anesthesia during endovascular therapy for acute anterior circulation stroke: preliminary results from a retrospective, multicenter study. Stroke J Cereb Circ 41(6):1175–1179. doi:10.1161/STROKEAHA.109.574129 CrossRef

Albers GW, Goldstein LB, Hess DC, Wechsler LR, Furie KL, Gorelick PB, Hurn P, Liebeskind DS, Nogueira RG, Saver JL, Consortium SV (2011) Stroke Treatment Academic Industry Roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies. Stroke J Cereb Circ 42(9):2645–2650. doi:10.1161/STROKEAHA.111.618850 CrossRef

Bailey EL, McCulloch J, Sudlow C, Wardlaw JM (2009) Potential animal models of lacunar stroke: a systematic review. Stroke J Cereb Circ 40(6):e451–e458. doi:10.1161/STROKEAHA.108.528430 CrossRef

Bailey EL, Smith C, Sudlow CL, Wardlaw JM (2011a) Is the spontaneously hypertensive stroke prone rat a pertinent model of sub cortical ischemic stroke? A systematic review. Int J Stroke Off J Int Stroke Soc 6(5):434–444. doi:10.1111/j.1747-4949.2011.00659.x CrossRef

Bailey EL, Wardlaw JM, Graham D, Dominiczak AF, Sudlow CL, Smith C (2011b) Cerebral small vessel endothelial structural changes predate hypertension in stroke-prone spontaneously hypertensive rats: a blinded, controlled immunohistochemical study of 5- to 21-week-old rats. Neuropathol Appl Neurobiol 37(7):711–726. doi:10.1111/j.1365-2990.2011.01170.x CrossRefPubMed

Banks JL, Marotta CA (2007) Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis. Stroke J Cereb Circ 38(3):1091–1096. doi:10.1161/01.STR.0000258355.23810.c6 CrossRef

Belayev L, Alonso OF, Busto R, Zhao W, Ginsberg MD (1996) Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model. Stroke J Cereb Circ 27(9):1616–1622, discussion 1623CrossRef

Broderick JP, Palesch YY, Demchuk AM, Yeatts SD, Khatri P, Hill MD, Jauch EC, Jovin TG, Yan B, Silver FL, von Kummer R, Molina CA, Demaerschalk BM, Budzik R, Clark WM, Zaidat OO, Malisch TW, Goyal M, Schonewille WJ, Mazighi M, Engelter ST, Anderson C, Spilker J, Carrozzella J, Ryckborst KJ, Janis LS, Martin RH, Foster LD, Tomsick TA, Interventional Management of Stroke IIII (2013) Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New Engl J Med 368(10):893–903. doi:10.1056/NEJMoa1214300 CrossRefPubMedCentralPubMed

Chapman DF, Lyden P, Lapchak PA, Nunez S, Thibodeaux H, Zivin J (2001) Comparison of TNK with wild-type tissue plasminogen activator in a rabbit embolic stroke model. Stroke J Cereb Circ 32(3):748–752CrossRef

Daugherty A, Lu H, Howatt DA, Rateri DL (2009) Modes of defining atherosclerosis in mouse models: relative merits and evolving standards. Methods Mol Biol 573:1–15. doi:10.1007/978-1-60761-247-6_1 CrossRefPubMed

Davis MJ, Menon BK, Baghirzada LB, Campos-Herrera CR, Goyal M, Hill MD, Archer DP, Calgary Stroke P (2012) Anesthetic management and outcome in patients during endovascular therapy for acute stroke. Anesthesiology 116(2):396–405. doi:10.1097/ALN.0b013e318242a5d2 CrossRefPubMed

Fearon P, McArthur KS, Garrity K, Graham LJ, McGroarty G, Vincent S, Quinn TJ (2012) Prestroke modified rankin stroke scale has moderate interobserver reliability and validity in an acute stroke setting. Stroke J Cereb Circ 43(12):3184–3188. doi:10.1161/STROKEAHA.112.670422 CrossRef

Feuerstein GZ, Zaleska MM, Krams M, Wang X, Day M, Rutkowski JL, Finklestein SP, Pangalos MN, Poole M, Stiles GL, Ruffolo RR, Walsh FL (2008) Missing steps in the STAIR case: a Translational Medicine perspective on the development of NXY-059 for treatment of acute ischemic stroke. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab 28(1):217–219. doi:10.1038/sj.jcbfm.9600516 CrossRef

Fisher M, Stroke Therapy Academic Industry R (2003) Recommendations for advancing development of acute stroke therapies: Stroke Therapy Academic Industry Roundtable 3. Stroke J Cereb Circ 34(6):1539–1546. doi:10.1161/01.STR.0000072983.64326.53 CrossRef

Fisher M, Albers GW, Donnan GA, Furlan AJ, Grotta JC, Kidwell CS, Sacco RL, Wechsler LR, Stroke Therapy Academic Industry Roundtable IV (2005) Enhancing the development and approval of acute stroke therapies: Stroke Therapy Academic Industry roundtable. Stroke J Cereb Circ 36(8):1808–1813. doi:10.1161/01.STR.0000173403.60553.27 CrossRef

Fisher M, Hanley DF, Howard G, Jauch EC, Warach S, Group S (2007) Recommendations from the STAIR V meeting on acute stroke trials, technology and outcomes. Stroke J Cereb Circ 38(2):245–248. doi:10.1161/01.STR.0000255951.37434.aa CrossRef

Fisher M, Feuerstein G, Howells DW, Hurn PD, Kent TA, Savitz SI, Lo EH, Group S (2009) Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke J Cereb Circ 40(6):2244–2250. doi:10.1161/STROKEAHA.108.541128 CrossRef

Flexman AM, Donovan AL, Gelb AW (2012) Anesthetic management of patients with acute stroke. Anesthesiol Clin 30(2):175–190. doi:10.1016/j.anclin.2012.04.002 CrossRefPubMed

Fox JG (1985) Laboratory-animal medicine changes and challenges. Cornell Vet 75(1):159–170PubMed

Froehler MT, Fifi JT, Majid A, Bhatt A, Ouyang M, McDonagh DL (2012) Anesthesia for endovascular treatment of acute ischemic stroke. Neurology 79(13 Suppl 1):S167–S173. doi:10.1212/WNL.0b013e31826959c2 CrossRefPubMed

Gakuba C, Gauberti M, Mazighi M, Defer G, Hanouz JL, Vivien D (2011) Preclinical evidence toward the use of ketamine for recombinant tissue-type plasminogen activator-mediated thrombolysis under anesthesia or sedation. Stroke J Cereb Circ 42(10):2947–2949. doi:10.1161/STROKEAHA.111.620468 CrossRef

Gelb AW, Bayona NA, Wilson JX, Cechetto DF (2002) Propofol anesthesia compared to awake reduces infarct size in rats. Anesthesiology 96(5):1183–1190CrossRefPubMed

Ginsberg MD, Palesch YY, Hill MD, Martin RH, Moy CS, Barsan WG, Waldman BD, Tamariz D, Ryckborst KJ, Alias, Neurological Emergencies Treatment Trials I (2013) High-dose albumin treatment for acute ischaemic stroke (ALIAS) Part 2: a randomised, double-blind, phase 3, placebo-controlled trial. Lancet Neurol 12(11):1049–1058. doi:10.1016/S1474-4422(13)70223-0 CrossRefPubMedCentralPubMed

Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D, E Investigators (2008) Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. New Engl J Med 359(13):1317–1329. doi:10.1056/NEJMoa0804656 CrossRefPubMed

Hainsworth AH, Markus HS (2008) Do in vivo experimental models reflect human cerebral small vessel disease? A systematic review. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab 28(12):1877–1891. doi:10.1038/jcbfm.2008.91 CrossRef

Head BP, Patel P (2007) Anesthetics and brain protection. Curr Opin Anaesthesiol 20(5):395–399CrossRefPubMed

Henninger N, Sicard KM, Schmidt KF, Bardutzky J, Fisher M (2006) Comparison of ischemic lesion evolution in embolic versus mechanical middle cerebral artery occlusion in Sprague Dawley rats using diffusion and perfusion imaging. Stroke J Cereb Circ 37(5):1283–1287. doi:10.1161/01.STR.0000217223.72193.98 CrossRef

Hossmann KA (2012) The two pathophysiologies of focal brain ischemia: implications for translational stroke research. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab 32(7):1310–1316. doi:10.1038/jcbfm.2011.186 CrossRef

Hsia AW, Sachdev HS, Tomlinson J, Hamilton SA, Tong DC (2003) Efficacy of IV tissue plasminogen activator in acute stroke: does stroke subtype really matter? Neurology 61(1):71–75CrossRefPubMed

Huybrechts KF, Caro JJ (2007) The Barthel Index and modified Rankin Scale as prognostic tools for long-term outcomes after stroke: a qualitative review of the literature. Curr Med Res Opin 23(7):1627–1636. doi:10.1185/030079907X210444 CrossRefPubMed

Jickling GC, Xu H, Stamova B, Ander BP, Zhan X, Tian Y, Liu D, Turner RJ, Mesias M, Verro P, Khoury J, Jauch EC, Pancioli A, Broderick JP, Sharp FR (2010) Signatures of cardioembolic and large-vessel ischemic stroke. Ann Neurol 68(5):681–692. doi:10.1002/ana.22187 CrossRefPubMedCentralPubMed

Jickling GC, Stamova B, Ander BP, Zhan X, Tian Y, Liu D, Xu H, Johnston SC, Verro P, Sharp FR (2011) Profiles of lacunar and nonlacunar stroke. Ann Neurol 70(3):477–485. doi:10.1002/ana.22497 CrossRefPubMedCentralPubMed

Karatas H, Erdener SE, Gursoy-Ozdemir Y, Gurer G, Soylemezoglu F, Dunn AK, Dalkara T (2011) Thrombotic distal middle cerebral artery occlusion produced by topical FeCl(3) application: a novel model suitable for intravital microscopy and thrombolysis studies. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab 31(6):1452–1460. doi:10.1038/jcbfm.2011.8 CrossRef

Kidwell CS, Jahan R, Gornbein J, Alger JR, Nenov V, Ajani Z, Feng L, Meyer BC, Olson S, Schwamm LH, Yoo AJ, Marshall RS, Meyers PM, Yavagal DR, Wintermark M, Guzy J, Starkman S, Saver JL, MR Investigators (2013) A trial of imaging selection and endovascular treatment for ischemic stroke. New Engl J Med 368(10):914–923. doi:10.1056/NEJMoa1212793 CrossRefPubMedCentralPubMed

Kirsch JR, Traystman RJ, Hurn PD (1996) Anesthetics and cerebroprotection: experimental aspects. Int Anesthesiol Clin 34(4):73–93CrossRefPubMed

Koerner IP, Brambrink AM (2006) Brain protection by anesthetic agents. Curr Opin Anaesthesiol 19(5):481–486CrossRefPubMed

Landis SC, Amara SG, Asadullah K, Austin CP, Blumenstein R, Bradley EW, Crystal RG, Darnell RB, Ferrante RJ, Fillit H, Finkelstein R, Fisher M, Gendelman HE, Golub RM, Goudreau JL, Gross RA, Gubitz AK, Hesterlee SE, Howells DW, Huguenard J, Kelner K, Koroshetz W, Krainc D, Lazic SE, Levine MS, Macleod MR, McCall JM, Moxley RT 3rd, Narasimhan K, Noble LJ, Perrin S, Porter JD, Steward O, Unger E, Utz U, Silberberg SD (2012) A call for transparent reporting to optimize the predictive value of preclinical research. Nature 490(7419):187–191. doi:10.1038/nature11556 CrossRefPubMedCentralPubMed

Lansberg MG, Lee J, Christensen S, Straka M, De Silva DA, Mlynash M, Campbell BC, Bammer R, Olivot JM, Desmond P, Davis SM, Donnan GA, Albers GW (2011) RAPID automated patient selection for reperfusion therapy: a pooled analysis of the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) and the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) Study. Stroke J Cereb Circ 42(6):1608–1614. doi:10.1161/STROKEAHA.110.609008 CrossRef

Lansberg MG, Straka M, Kemp S, Mlynash M, Wechsler LR, Jovin TG, Wilder MJ, Lutsep HL, Czartoski TJ, Bernstein RA, Chang CW, Warach S, Fazekas F, Inoue M, Tipirneni A, Hamilton SA, Zaharchuk G, Marks MP, Bammer R, Albers GW, investigators Ds (2012) MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study. Lancet Neurol 11(10):860–867. doi:10.1016/S1474-4422(12)70203-X CrossRefPubMedCentralPubMed

Lapchak PA (2009) Effect of internal carotid artery reperfusion in combination with Tenecteplase on clinical scores and hemorrhage in a rabbit embolic stroke model. Brain Res 1294:211–217. doi:10.1016/j.brainres.2009.07.058 CrossRefPubMed

Lapchak PA (2010) Translational stroke research using a rabbit embolic stroke model: a correlative analysis hypothesis for novel therapy development. Transl Stroke Res 1(2):96–107. doi:10.1007/s12975-010-0018-4 CrossRefPubMedCentralPubMed

Lapchak PA, Araujo DM, Pakola S, Song D, Wei J, Zivin JA (2002a) Microplasmin: a novel thrombolytic that improves behavioral outcome after embolic strokes in rabbits. Stroke J Cereb Circ 33(9):2279–2284CrossRef

Lapchak PA, Araujo DM, Song D, Wei J, Zivin JA (2002b) Neuroprotective effects of the spin trap agent disodium-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) in a rabbit small clot embolic stroke model: combination studies with the thrombolytic tissue plasminogen activator. Stroke J Cereb Circ 33(5):1411–1415CrossRef

Lapchak PA, Zhang JH, Noble-Haeusslein LJ (2013) RIGOR Guidelines: Escalating STAIR and STEPS for effective translational research. Transl Stroke Res 4(3):279–285. doi:10.1007/s12975-012-0209-2 CrossRefPubMedCentralPubMed

Liou SY, Stringer F, Hirayama M (2012) The impact of pharmacogenomics research on drug development. Drug Metab Pharmacokinet 27(1):2–8CrossRefPubMed

Meyer DM, Compton P, Eastwood JA, Gylys K, Zivin JA (2013) Antiplatelet loading improves behavioral outcome in a rabbit model of stroke. Stroke J Cereb Circ 44(11):3246–3248. doi:10.1161/STROKEAHA.113.002565 CrossRef

O’Collins VE, Macleod MR, Donnan GA, Horky LL, van der Worp BH, Howells DW (2006) 1,026 experimental treatments in acute stroke. Ann Neurol 59(3):467–477. doi:10.1002/ana.20741 CrossRefPubMed

Orset C, Macrez R, Young AR, Panthou D, Angles-Cano E, Maubert E, Agin V, Vivien D (2007) Mouse model of in situ thromboembolic stroke and reperfusion. Stroke J Cereb Circ 38(10):2771–2778. doi:10.1161/STROKEAHA.107.487520 CrossRef

Plenge RM, Scolnick EM, Altshuler D (2013) Validating therapeutic targets through human genetics. Nat Rev Drug Discov 12(8):581–594. doi:10.1038/nrd4051 CrossRefPubMed

Quinn TJ, Dawson J, Walters MR, Lees KR (2009) Reliability of the modified Rankin Scale: a systematic review. Stroke J Cereb Circ 40(10):3393–3395. doi:10.1161/STROKEAHA.109.557256 CrossRef

Reagan-Shaw S, Nihal M, Ahmad N (2008) Dose translation from animal to human studies revisited. FASEB J Off Publ Fed Am Soc Exp Biol 22(3):659–661. doi:10.1096/fj.07-9574LSF

Rosell A, Agin V, Rahman M, Morancho A, Ali C, Koistinaho J, Wang X, Vivien D, Schwaninger M, Montaner J (2013) Distal occlusion of the middle cerebral artery in mice: are we ready to assess long-term functional outcome? Transl Stroke Res 4(3):297–307. doi:10.1007/s12975-012-0234-1 CrossRefPubMed

Russell JC, Proctor SD (2006) Small animal models of cardiovascular disease: tools for the study of the roles of metabolic syndrome, dyslipidemia, and atherosclerosis. Cardiovasc Pathol Off J Soc Cardiovasc Pathol 15(6):318–330. doi:10.1016/j.carpath.2006.09.001 CrossRef

Saver JL, Albers GW, Dunn B, Johnston KC, Fisher M, Consortium SV (2009) Stroke Therapy Academic Industry Roundtable (STAIR) recommendations for extended window acute stroke therapy trials. Stroke J Cereb Circ 40(7):2594–2600. doi:10.1161/STROKEAHA.109.552554 CrossRef

Sicard KM, Fisher M (2009) Animal models of focal brain ischemia. Exp Transl Stroke Med 1:7–7CrossRefPubMedCentralPubMed

Singh SS (2006) Preclinical pharmacokinetics: an approach towards safer and efficacious drugs. Current Drug Metab 7(2):165–182CrossRef

Stamova B, Xu H, Jickling G, Bushnell C, Tian Y, Ander BP, Zhan X, Liu D, Turner R, Adamczyk P, Khoury JC, Pancioli A, Jauch E, Broderick JP, Sharp FR (2010) Gene expression profiling of blood for the prediction of ischemic stroke. Stroke J Cereb Circ 41(10):2171–2177. doi:10.1161/STROKEAHA.110.588335 CrossRef

Stroke Therapy Academic Industry R, II (2001) Recommendations for clinical trial evaluation of acute stroke therapies. Stroke J Cereb Circ 32(7):1598–1606CrossRef

Takano K, Tatlisumak T, Bergmann AG, Gibson DG 3rd, Fisher M (1997) Reproducibility and reliability of middle cerebral artery occlusion using a silicone-coated suture (Koizumi) in rats. J Neurol Sci 153(1):8–11CrossRefPubMed

Tang Y, Lu A, Aronow BJ, Sharp FR (2001) Blood genomic responses differ after stroke, seizures, hypoglycemia, and hypoxia: blood genomic fingerprints of disease. Ann Neurol 50(6):699–707CrossRefPubMed

Tang Y, Xu H, Du X, Lit L, Walker W, Lu A, Ran R, Gregg JP, Reilly M, Pancioli A, Khoury JC, Sauerbeck LR, Carrozzella JA, Spilker J, Clark J, Wagner KR, Jauch EC, Chang DJ, Verro P, Broderick JP, Sharp FR (2006) Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab 26(8):1089–1102. doi:10.1038/sj.jcbfm.9600264 CrossRef

The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. New Engl J Med 333(24):1581–1587. doi:10.1056/NEJM199512143332401 CrossRef

Verbeuren TJ (2006) Experimental models of thrombosis and atherosclerosis. Therapie 61(5):379–387CrossRefPubMed

Wang L, Jing W, Hang YN (2008) Glutamate-induced c-Jun expression in neuronal PC12 cells: the effects of ketamine and propofol. J Neurosurg Anesthesiol 20(2):124–130CrossRefPubMed

Weisscher N, Vermeulen M, Roos YB, de Haan RJ (2008) What should be defined as good outcome in stroke trials; a modified Rankin score of 0–1 or 0–2? J Neurol 255(6):867–874. doi:10.1007/s00415-008-0796-8 CrossRefPubMed

Yanni AE (2004) The laboratory rabbit: an animal model of atherosclerosis research. Lab Anim 38(3):246–256. doi:10.3201/eid0905.020321 CrossRefPubMed

Yao H, Nabika T (2012) Standards and pitfalls of focal ischemia models in spontaneously hypertensive rats: with a systematic review of recent articles. J Transl Med 10:139. doi:10.1186/1479-5876-10-139 CrossRefPubMedCentralPubMed

Zhang GY, Chen ZQ, Ling F, Li YJ, Wang Y, Gu BX (2010) Establishment of a novel hemodynamic cerebral ischemia model of atherosclerotic rabbit. Neurol India 58(2):191–194. doi:10.4103/0028-3886.63782 CrossRefPubMed

Zhao H, Collier JM, Quah DM, Purvis T, Bernhardt J (2010) The modified Rankin Scale in acute stroke has good inter-rater-reliability but questionable validity. Cerebrovasc Dis 29(2):188–193. doi:10.1159/000267278 CrossRefPubMed

Zivin JA, Fisher M, DeGirolami U, Hemenway CC, Stashak JA (1985) Tissue plasminogen activator reduces neurological damage after cerebral embolism. Science 230(4731):1289–1292CrossRefPubMed

Titel: Improving the translation of animal ischemic stroke studies to humans
verfasst von: Glen C. Jickling
Frank R. Sharp
Publikationsdatum: 01.04.2015
Verlag: Springer US
Erschienen in: Metabolic Brain Disease / Ausgabe 2/2015
Print ISSN: 0885-7490
Elektronische ISSN: 1573-7365
DOI: https://doi.org/10.1007/s11011-014-9499-2

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2015

Hyperglycemia / hypoglycemia-induced mitochondrial dysfunction and cerebral ischemic damage in diabetics

Indomethacin reverses decreased hippocampal cell proliferation in streptozotocin-induced diabetic mice

Recent advances in the pharmacologic treatment of spinal cord injury

Ablation of matrix metalloproteinase-9 gene decreases cerebrovascular permeability and fibrinogen deposition post traumatic brain injury in mice

Behavioral effects of citrus limon in rats